Helix BioMedix (HXBM) Ratios
Helix BioMedix Ratios
HXBM's free cash flow for Q? was ―. For the fiscal year, HXBM's free cash flow was increased by ― and operating cash flow was ―. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 12.16 | 44.99 | 30.24 | 55.34 | 1.68 |
| Quick Ratio | 12.16 | 44.99 | 30.24 | 55.29 | 1.64 |
| Cash Ratio | 9.20 | 38.40 | 27.20 | 33.73 | 1.47 |
| Solvency Ratio | -3.97 | -15.63 | -9.34 | -12.52 | -0.54 |
| Operating Cash Flow Ratio | -4.37 | -13.00 | -5.76 | -9.90 | -0.20 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -10.22 | 0.00 | -0.23 |
| Net Current Asset Value | $ 1.54M | $ 2.94M | $ 3.69M | $ 4.67M | $ 2.17M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.02 | 0.00 | 0.52 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.02 | 0.00 | 1.30 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.02 | 0.00 | 0.57 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Financial Leverage Ratio | 1.09 | 1.02 | 1.03 | 1.02 | 2.52 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -16.57 | -2.83 | -0.34 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -3.76 | -1.87 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.00 | 0.57 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.32 | 1.56 | 17.40 |
| Net Debt to EBITDA | 2.32 | 2.46 | 2.85 | 2.93 | 1.64 |
| Profitability Margins | |||||
| Gross Profit Margin | 99.36% | 99.02% | 99.11% | 81.30% | 94.40% |
| EBIT Margin | -68.32% | -105.85% | -67.94% | -42.50% | -65.25% |
| EBITDA Margin | -67.68% | -104.87% | -67.22% | -41.94% | -64.80% |
| Operating Profit Margin | -73.81% | -98.63% | -61.48% | -55.75% | -67.03% |
| Pretax Profit Margin | -68.32% | -105.85% | -67.94% | -57.32% | -101.01% |
| Net Profit Margin | -68.32% | -105.85% | -67.94% | -57.32% | -101.01% |
| Continuous Operations Profit Margin | -68.32% | -105.85% | -67.94% | -57.32% | -101.01% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 92.56% | 107.32% | 110.51% | 102.80% | 150.69% |
| Return on Assets (ROA) | -32.90% | -34.91% | -30.33% | -28.12% | -32.87% |
| Return on Equity (ROE) | -35.84% | -35.70% | -31.34% | -28.76% | -82.76% |
| Return on Capital Employed (ROCE) | -38.72% | -33.27% | -28.36% | -27.85% | -52.77% |
| Return on Invested Capital (ROIC) | -38.72% | -33.27% | -27.84% | -27.85% | -23.73% |
| Return on Tangible Assets | -32.90% | -34.91% | -30.33% | -28.12% | -32.87% |
| Earnings Yield | -122.72% | -20.20% | -22.77% | -50.45% | -36.41% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.56 | 3.19 | 6.84 | 5.09 | 4.23 |
| Payables Turnover | 0.42 | 0.22 | 3.68 | 18.75 | 3.06 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 120.49 | 0.71 |
| Fixed Asset Turnover | 2453.47 | 83.44 | 17.55 | 61.77 | 41.60 |
| Asset Turnover | 0.48 | 0.33 | 0.45 | 0.49 | 0.33 |
| Working Capital Turnover Ratio | 0.45 | 0.30 | 0.42 | 0.68 | 0.00 |
| Cash Conversion Cycle | -722.32 | -1526.81 | -45.72 | 55.25 | 481.60 |
| Days of Sales Outstanding | 142.69 | 114.47 | 53.36 | 71.68 | 86.26 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 3.03 | 514.73 |
| Days of Payables Outstanding | 865.01 | 1641.28 | 99.08 | 19.47 | 119.39 |
| Operating Cycle | 142.69 | 114.47 | 53.36 | 74.71 | 600.99 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.67 | -3.87 | -3.24 | -3.80 | -3.25 |
| Free Cash Flow Per Share | -2.67 | -3.88 | -3.24 | -3.84 | -3.45 |
| Dividend Paid and CapEx Coverage Ratio | -200355.67 | -660.25 | -541.06 | -112.49 | -16.22 |
| Capital Expenditure Coverage Ratio | -200355.67 | -660.25 | -541.06 | -112.49 | -16.22 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -10.22 | 0.00 | -0.23 |
| Operating Cash Flow to Sales Ratio | -0.74 | -0.87 | -0.41 | -0.36 | -0.36 |
| Free Cash Flow Yield | -133.75% | -16.67% | -13.93% | -31.98% | -13.91% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.82 | -4.95 | -4.39 | -1.98 | -2.75 |
| Price-to-Sales (P/S) Ratio | 0.56 | 5.24 | 2.98 | 1.14 | 2.77 |
| Price-to-Book (P/B) Ratio | 0.29 | 1.77 | 1.38 | 0.57 | 2.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.75 | -6.00 | -7.18 | -3.13 | -7.19 |
| Price-to-Operating Cash Flow Ratio | -0.75 | -6.01 | -7.19 | -3.16 | -7.63 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | 0.43 | 0.36 | 0.06 | 0.00 |
| Enterprise Value Multiple | 1.50 | -2.54 | -1.59 | 0.22 | -2.64 |
| Enterprise Value | -817.09K | 2.66M | 1.87M | -216.75K | 3.14M |
| EV to EBITDA | 1.50 | -2.54 | -1.59 | 0.22 | -2.64 |
| EV to Sales | -1.01 | 2.66 | 1.07 | -0.09 | 1.71 |
| EV to Free Cash Flow | 1.36 | -3.05 | -2.57 | 0.25 | -4.43 |
| EV to Operating Cash Flow | 1.36 | -3.06 | -2.57 | 0.25 | -4.70 |
| Tangible Book Value Per Share | 6.85 | 13.16 | 16.93 | 21.05 | 10.91 |
| Shareholders’ Equity Per Share | 6.85 | 13.16 | 16.93 | 21.05 | 10.91 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 3.59 | 4.44 | 7.81 | 10.56 | 8.94 |
| Net Income Per Share | -2.45 | -4.70 | -5.31 | -6.05 | -9.03 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.35 | 1.55 |
| Research & Development to Revenue | 0.22 | 0.32 | 0.51 | 0.52 | 0.55 |
| SG&A to Revenue | 1.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.09 | 0.82 | 0.61 | 0.63 | 0.36 |
Currency in USD
